[Mouth and pharyngeal hyperalgesic syndromes in AIDS].
In a series of 12 patients suffering from an HIV infection, including 9 with confirmed AIDS, who complained about pharyngeal pain in a fixed site, having a progressive intensity and not relieved by antalgics and the specific treatments that were prescribed empirically, and for whom etiological investigation yielded negative results, Thalidomide proved to be the only effective means of healing the exulcerated, nail-mark lesions or the ulcerated, budding, neoplastic-like lesions, and of completely suppressing pain.
Gehanno
P
P
Service ORL, Groupe Hospitalier Bichat-Claude-Bernard, Paris.
Barry
B
B
Depondt
J
J
Guedon
C
C
Poignonec
S
S
Leport
C
C
Gorin
I
I
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy / Q000209:etiology*; D010146:Pain / Q000188:drug therapy / Q000209:etiology*; D010608:Pharyngeal Diseases / Q000188:drug therapy / Q000209:etiology*; D013792:Thalidomide / Q000627:therapeutic use; D014456:Ulcer / Q000188:drug therapy / Q000209:etiology
D013792:Thalidomide
Syndromes hyperalgiques bucco-pharyngés observés au cours du SIDA.